Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
CTMX holding history
CytomX Therapeutics, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −564,800−100.0% | Sold out | Holders |
| Q3 2025 | 564,800 | $1.80M | 0.4% | −2,952,313−83.9% | Reduced | Holders |
| Q2 2025 | 3,517,113 | $7.98M | 1.9% | −412,895−10.5% | Reduced | Holders |
| Q1 2025 | 3,930,008 | $2.50M | 0.8% | +25,008+0.6% | Added | Holders |
| Q4 2024 | 3,905,000 | $4.02M | 1.1% | +882,891+29.2% | Added | Holders |
| Q3 2024 | 3,022,109 | $3.57M | 0.9% | +3,022,109 | New | Holders |